Sensus Healthcare Past Earnings Performance
Past criteria checks 2/6
Sensus Healthcare has been growing earnings at an average annual rate of 38.1%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 14.6% per year. Sensus Healthcare's return on equity is 17.2%, and it has net margins of 22.5%.
Key information
38.1%
Earnings growth rate
38.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 14.6% |
| Return on equity | 17.2% |
| Net Margin | 22.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
We Think Sensus Healthcare (NASDAQ:SRTS) Might Have The DNA Of A Multi-Bagger
Dec 18
Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 19Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares
Nov 12At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
Oct 03Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up
May 12Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk
Apr 16Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17Revenue & Expenses Breakdown
How Sensus Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 41 | 9 | 10 | 3 |
| 30 Jun 24 | 36 | 7 | 10 | 4 |
| 31 Mar 24 | 32 | 5 | 10 | 4 |
| 31 Dec 23 | 24 | 0 | 11 | 4 |
| 30 Sep 23 | 25 | -1 | 12 | 4 |
| 30 Jun 23 | 30 | 2 | 12 | 4 |
| 31 Mar 23 | 38 | 6 | 12 | 4 |
| 31 Dec 22 | 45 | 24 | 11 | 3 |
| 30 Sep 22 | 44 | 27 | 11 | 3 |
| 30 Jun 22 | 41 | 25 | 10 | 3 |
| 31 Mar 22 | 34 | 21 | 10 | 4 |
| 31 Dec 21 | 27 | 4 | 9 | 3 |
| 30 Sep 21 | 19 | 0 | 9 | 3 |
| 30 Jun 21 | 15 | -2 | 9 | 3 |
| 31 Mar 21 | 11 | -4 | 8 | 4 |
| 31 Dec 20 | 10 | -7 | 9 | 4 |
| 30 Sep 20 | 13 | -7 | 11 | 4 |
| 30 Jun 20 | 17 | -6 | 12 | 5 |
| 31 Mar 20 | 24 | -3 | 13 | 6 |
| 31 Dec 19 | 27 | -2 | 13 | 6 |
| 30 Sep 19 | 27 | -3 | 13 | 7 |
| 30 Jun 19 | 27 | -2 | 13 | 7 |
| 31 Mar 19 | 26 | -3 | 13 | 7 |
| 31 Dec 18 | 26 | -2 | 13 | 6 |
| 30 Sep 18 | 25 | -3 | 12 | 6 |
| 30 Jun 18 | 23 | -3 | 12 | 6 |
| 31 Mar 18 | 22 | -3 | 12 | 6 |
| 31 Dec 17 | 21 | -4 | 12 | 5 |
| 30 Sep 17 | 19 | -3 | 12 | 5 |
| 30 Jun 17 | 18 | -2 | 11 | 3 |
| 31 Mar 17 | 16 | -2 | 10 | 3 |
| 31 Dec 16 | 15 | 0 | 8 | 2 |
| 30 Sep 16 | 14 | 0 | 7 | 1 |
| 30 Jun 16 | 13 | 0 | 7 | 1 |
| 31 Mar 16 | 11 | 0 | 6 | 1 |
| 31 Dec 15 | 10 | -1 | 5 | 1 |
| 30 Sep 15 | 8 | -2 | 5 | 2 |
| 31 Dec 14 | 6 | -4 | 6 | 2 |
| 31 Dec 13 | 10 | 0 | 5 | 1 |
Quality Earnings: SRTS has a high level of non-cash earnings.
Growing Profit Margin: SRTS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRTS has become profitable over the past 5 years, growing earnings by 38.1% per year.
Accelerating Growth: SRTS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SRTS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).
Return on Equity
High ROE: SRTS's Return on Equity (17.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 13:57 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sensus Healthcare, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew D'Silva | B. Riley Securities, Inc. |
| Alexander Nowak | Craig-Hallum Capital Group LLC |
| Ilya Zubkov | Freedom Broker |